CVS Health Corporation

NYSE:CVS Rapport sur les actions

Capitalisation boursière : US$73.4b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

CVS Health Croissance future

Future contrôle des critères 1/6

CVS Health devrait augmenter ses bénéfices et son chiffre d'affaires de 10% et de 4.8% par an respectivement. Le BPA devrait croître de de 10.8% par an. Le rendement des capitaux propres devrait être 11.7% dans 3 ans.

Informations clés

10.0%

Taux de croissance des bénéfices

10.8%

Taux de croissance du BPA

Healthcare croissance des bénéfices19.3%
Taux de croissance des recettes4.8%
Rendement futur des capitaux propres11.7%
Couverture par les analystes

Good

Dernière mise à jour21 Aug 2024

Mises à jour récentes de la croissance future

CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

May 03
CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Recent updates

A Piece Of The Puzzle Missing From CVS Health Corporation's (NYSE:CVS) Share Price

Aug 08
A Piece Of The Puzzle Missing From CVS Health Corporation's (NYSE:CVS) Share Price

CVS Health Q2 Earnings: CEO's Swinging Axe May Have Ended The Bear Run

Aug 07

Here's Why CVS Health (NYSE:CVS) Has A Meaningful Debt Burden

Jul 21
Here's Why CVS Health (NYSE:CVS) Has A Meaningful Debt Burden

CVS Health: A Better Investment Than Walgreens Boots Alliance

Jul 09

Vltava Fund - CVS Health Corp.: Why We Sold CVS

Jul 03

CVS Health: Mismanagement, Eroding Moat And Poor Momentum Make It A Sell

Jun 21

The Correct Play On CVS Health

Jun 06

CVS Health: Downside Movement Is Overdramatic

May 26

CVS Health: Secure Dividend And Upside Potential Presents Compelling Opportunity

May 15

We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now

May 10
We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now

CVS Health: A Terrible Earnings Report, But An Undervalued Stock

May 04

CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

May 03
CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

CVS Health: 8x P/E, 8% Growth Projection - It's A Market Blind Spot

Apr 22

Sentiment Still Eluding CVS Health Corporation (NYSE:CVS)

Apr 14
Sentiment Still Eluding CVS Health Corporation (NYSE:CVS)

CVS Health: Lookback, Management Guidance Vs. Results 2018-To-Date

Apr 10

Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?

Mar 27
Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?

CVS Health: Better Times Likely Ahead

Mar 12

CVS Health: Lower Guidance But Risk/Reward Remains Attractive

Feb 15

CVS Health FY23 Earnings: Downgrades Inevitable, Long Term Outlook In The Balance

Feb 07

CVS Health: Back In The Buy Column

Jan 21

CVS Health (NYSE:CVS) Has Announced That It Will Be Increasing Its Dividend To $0.665

Jan 17
CVS Health (NYSE:CVS) Has Announced That It Will Be Increasing Its Dividend To $0.665

CVS Health: Shares Remain Modestly Undervalued, Robust Free Cash Flow, Technical Strength

Jan 08

CVS Health (NYSE:CVS) Is Paying Out A Larger Dividend Than Last Year

Jan 03
CVS Health (NYSE:CVS) Is Paying Out A Larger Dividend Than Last Year

CVS Health: Risk/Reward Highly Skewed To The Upside

Dec 15

CVS Health (NYSE:CVS) Is Increasing Its Dividend To $0.665

Dec 13
CVS Health (NYSE:CVS) Is Increasing Its Dividend To $0.665

We Think CVS Health (NYSE:CVS) Is Taking Some Risk With Its Debt

Dec 08
We Think CVS Health (NYSE:CVS) Is Taking Some Risk With Its Debt

CVS Health: A Good Fit To Buffett's 10x Pretax Rule

Dec 07

Prévisions de croissance des bénéfices et des revenus

NYSE:CVS - Estimations futures des analystes et données financières antérieures (USD Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/2026408,1599,48111,61714,24516
12/31/2025386,5358,08110,43712,30724
12/31/2024369,0306,6819,26710,99624
6/30/2024361,8557,1905,2738,072N/A
3/31/2024359,6627,3218,13910,891N/A
12/31/2023356,6238,34410,39513,426N/A
9/30/2023346,6018,63211,30214,110N/A
6/30/2023338,0722,96517,67420,517N/A
3/31/2023329,9154,09317,39220,052N/A
12/31/2022321,6294,31113,45016,177N/A
9/30/2022314,3433,28319,49822,134N/A
6/30/2022306,9338,28715,86818,532N/A
3/31/2022298,7708,04116,19418,936N/A
12/31/2021290,9128,00115,74518,265N/A
9/30/2021283,9817,58615,19117,827N/A
6/30/2021277,2857,21211,61814,180N/A
3/31/2021270,1157,40412,92815,452N/A
12/31/2020267,9087,18813,42815,865N/A
9/30/2020265,2857,95112,64114,932N/A
6/30/2020262,9808,25713,62815,986N/A
3/31/2020260,9617,21711,72214,205N/A
12/31/2019255,7656,62910,39112,848N/A
9/30/2019243,3314,46410,21812,693N/A
6/30/2019226,0534,3248,44810,862N/A
3/31/2019209,623-1746,1878,458N/A
12/31/2018193,919-5976,8288,865N/A
9/30/2018188,0553,0984,2926,250N/A
6/30/2018186,9672,9895,8227,764N/A
3/31/2018185,9446,645N/A6,829N/A
12/31/2017184,7656,606N/A8,007N/A
9/30/2017182,3515,029N/A10,264N/A
6/30/2017180,7855,281N/A11,587N/A
3/31/2017178,8255,108N/A11,235N/A
12/31/2016177,5265,291N/A10,141N/A
9/30/2016172,7015,084N/A11,591N/A
6/30/2016166,7294,781N/A9,477N/A
3/31/2016160,1735,126N/A8,867N/A
12/31/2015153,2905,202N/A8,539N/A
9/30/2015149,1995,027N/A8,264N/A
6/30/2015145,5774,741N/A8,089N/A
3/31/2015143,0104,713N/A7,949N/A
12/31/2014139,3674,626N/A8,137N/A
9/30/2014135,1424,576N/A6,252N/A
6/30/2014132,0534,887N/A6,310N/A
3/31/2014128,6994,775N/A6,315N/A
12/31/2013126,7614,600N/A5,783N/A
9/30/2013125,3124,450N/A5,976N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de CVS ( 10% par an) est supérieure au taux d'épargne ( 2.5% ).

Bénéfices vs marché: Les bénéfices de CVS ( 10% par an) devraient croître plus lentement que le marché US ( 15.2% par an).

Croissance élevée des bénéfices: Les bénéfices de CVS devraient augmenter, mais pas de manière significative.

Chiffre d'affaires vs marché: Le chiffre d'affaires de CVS ( 4.8% par an) devrait croître plus lentement que le marché de US ( 8.8% par an).

Croissance élevée des revenus: Le chiffre d'affaires de CVS ( 4.8% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de CVS devrait être faible dans 3 ans ( 11.7 %).

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y